Question 1

Does Price T Rowe Associates own MEDP stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Price T Rowe Associates holds 2,069,677 shares of MEDP (Medpace), worth $1.1B.

Question 2

How many shares of MEDP does Price T Rowe Associates own?

Accepted Answer

As of its Q2 2026 13F, Price T Rowe Associates holds 2,069,677 shares of MEDP (Medpace).

Question 3

What is Price T Rowe Associates' MEDP position worth?

Accepted Answer

As of its Q2 2026 13F, Price T Rowe Associates' MEDP position is worth $1.1B.

Question 4

Is Price T Rowe Associates buying or selling MEDP?

Accepted Answer

In Q2 2026, Price T Rowe Associates increased its MEDP position from 289,507 to 2,069,677 shares.

Question 5

When did Price T Rowe Associates first buy MEDP?

Accepted Answer

Price T Rowe Associates already held MEDP in its Q3 2019 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	2.1M	+614.9%	$1.1B	0.1%	$529.59	62
2026-Q1	Increased	289,507	+148.3%	$139M	0.0%	$480.19	49
2025-Q4	Increased	116,581	+13.9%	$65.5M	0.0%	$561.65	34
2025-Q3	Decreased	102,328	-0.9%	$52.6M	0.0%	$514.16	0
2025-Q2	Decreased	103,304	-3.8%	$32.4M	0.0%	$313.86	0
2025-Q1	Decreased	107,375	-14.6%	$32.7M	0.0%	$304.69	0
2024-Q4	Decreased	125,718	-4.4%	$41.8M	0.0%	$332.23	0
2024-Q3	Decreased	131,532	-14.8%	$43.9M	0.0%	$333.80	0